Skip to main content

Table 2 Methotrexate and biologic use and tapering in SJIA: physician practices, CARRA workgroup survey

From: Physician practices for withdrawal of medications in inactive systemic juvenile arthritis, Childhood Arthritis and Rheumatology Research Alliance (CARRA) survey

Medication

Never use this CTP

% (n)

Stop immediately

% (n)

Taper over weeks to < 2 months

% (n)

Taper over 2–6 months

% (n)

Taper over > 6 months

% (n)

Methotrexate

19 (14)

7 (5)

4 (3)

35 (26)

35 (26)

Anakinra

5.3 (4)

9.3 (7)

25.3 (19)

38.7 (29)

21.3 (16)

Canakinumab

14.7 (11)

12 (9)

4 (3)

36 (27)

33.3 (25)

Rilonacept

69.3 (52)

2.7 (2)

2.7 (2)

16 (12)

(9.3 (7)

Tocilizumab

2.7 (2)

4 (3)

6.7 (5)

46.7 (35)

40 (30)

  1. Abbreviation: SJIA Systemic juvenile idiopathic arthritis, CARRA Childhood Arthritis and Rheumatology Research Alliance, CTP Consensus treatment plan [4]